UNSPSC 51391727: Methoxamine

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HUQ1KC1YLI, chemically known as 2-amino-1-(2,5-dimethoxyphenyl)propanol but generally known as methoxamine, which bears US NIH Compound Identifier 6082. European Medicines Agency schedules Methoxamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08857MIG.

UNSPSC 51391727 Methoxamine is a Commodity code that nominally describes a single pharmaceutical product, but recent state and local activity under this code shows a broader procurement pattern: state and local health agencies are buying naloxone and drug deactivation systems as part of community health and pharmacy benefit initiatives. The work involves the supply and delivery of emergency medications and harm-reduction equipment to support public health objectives, including overdose response and controlled substance management. Issuing bodies include county health departments and state health and human services agencies soliciting through competitive bidding and exploratory information-gathering processes.

Seminole County, Florida and the Texas Health and Human Services Commission represent the recent activity in this code space. Seminole County issued IFB 60459723LAS on June 30, 2026, to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford, with a response deadline of July 26, 2023 (note: this date predates the posting and appears inconsistent in the source). The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capability information for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information about direct contracting capacity and outcomes-based agreement models rather than executing an immediate procurement. Both opportunities reflect state and local emphasis on pharmacy supply chain efficiency and emergency medication access, though the geographic spread in the recent record is limited to Florida and Texas.